We are live on ! Find out more
H

HoyleCohen Portfolio holdings

AUM $1.32B
1-Year Est. Return 27.05%
This Fund
S&P 500
This Quarter Est. Return
+9.31%
1 Year Est. Return
+27.05%
3 Year Est. Return
+46.07%
5 Year Est. Return
+145.61%
10 Year Est. Return
AUM
$1.13B
AUM Growth
+$61.7M
Cap. Flow
-$23.4M
Cap. Flow %
-2.07%
Top 10 Hldgs %
32.59%
Holding
268
New
10
Increased
71
Reduced
127
Closed
7

Top Sells

Rank Stock Value
1
SCHA icon
Schwab U.S Small- Cap ETF
SCHA
+$14.8M
2
AAPL icon
Apple
AAPL
+$2.78M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.01M
4
MSFT icon
Microsoft
MSFT
+$794K
5
V icon
Visa
V
+$790K

Sector Composition

Rank Sector Weight
1 Technology 25.19%
2 Financials 10.55%
3 Healthcare 8.3%
4 Communication Services 6.34%
5 Industrials 5.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCHX icon
251
Schwab US Large- Cap ETF
SCHX
$70.9B
$202K 0.02%
11,556
-4,524
-28% -$74.7K
AFIF icon
252
Anfield Universal Fixed Income ETF
AFIF
$227M
$196K 0.02%
22,218
SMMT icon
253
Summit Therapeutics
SMMT
$10.9B
$187K 0.02%
74,408
WBD icon
254
Warner Bros
WBD
$64.6B
$156K 0.01%
12,471
-27
-0.2% -$350
INFN
255
DELISTED
Infinera Corporation Common Stock
INFN
$130K 0.01%
27,000
AKTS
256
DELISTED
Akoustis Technologies Inc
AKTS
$117K 0.01%
36,902
NAC icon
257
Nuveen California Quality Municipal Income Fund
NAC
$1.83B
$115K 0.01%
10,575
-1,156
-10% -$12.5K
PSNL icon
258
Personalis
PSNL
$1.26B
$28.9K ﹤0.01%
15,373
SLGC
259
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$27.1K ﹤0.01%
+11,714
New +$33.1K
VIRX
260
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$19.7K ﹤0.01%
14,000
TCON
261
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$3.78K ﹤0.01%
650
GEHC icon
262
GE HealthCare
GEHC
$27.6B
-2,648
Closed -$217K
MA icon
263
Mastercard
MA
$477B
-612
Closed -$222K
MRNA icon
264
Moderna
MRNA
$21.5B
-1,474
Closed -$226K
PCY icon
265
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.38B
-23,100
Closed -$443K
PD icon
266
PagerDuty
PD
$700M
-5,925
Closed -$207K
PSX icon
267
Phillips 66
PSX
$82.9B
-2,008
Closed -$204K
TIP icon
268
iShares TIPS Bond ETF
TIP
$14.5B
-4,380
Closed -$483K

Similar funds

HoyleCohen's Q2 2023 Portfolio in Review

As of Q2 2023, HoyleCohen held 268 positions worth $1.13B, up 5.8% from $1.07B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

HoyleCohen's Q2 2023 filing shows 10 new, 71 increased, 127 reduced and 7 closed positions. Its largest new stake was Vanguard FTSE Europe ETF: 40,175 shares worth $2.48M. The largest sale was Schwab U.S Small- Cap ETF, an estimated $14.8M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • HoyleCohen's largest Q2 2023 buy was Vanguard FTSE Europe ETF: 40,175 shares worth $2.48M.
  • HoyleCohen added most to Vanguard Growth ETF in Q2 2023, an estimated $1.58M increase.
  • HoyleCohen's biggest Q2 2023 reduction was Schwab U.S Small- Cap ETF, cutting an estimated $14.8M.
  • HoyleCohen fully exited iShares TIPS Bond ETF in Q2 2023, selling an estimated $483K.
  • HoyleCohen's ten largest holdings make up 33% of its $1.13B portfolio in Q2 2023.
  • HoyleCohen opened 10 new positions and closed 7 in Q2 2023.
  • HoyleCohen's portfolio value rose 5.8% quarter-over-quarter to $1.13B.

Based on HoyleCohen's 13F filing for Q2 2023, filed 7 Aug 2023.